NM_001122752.2:c.-19+1394T>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001122752.2(SERPINI1):c.-19+1394T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.559 in 151,888 control chromosomes in the GnomAD database, including 26,487 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.56 ( 26487 hom., cov: 31)
Consequence
SERPINI1
NM_001122752.2 intron
NM_001122752.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.257
Publications
4 publications found
Genes affected
SERPINI1 (HGNC:8943): (serpin family I member 1) This gene encodes a member of the serpin superfamily of serine proteinase inhibitors. The protein is primarily secreted by axons in the brain, and preferentially reacts with and inhibits tissue-type plasminogen activator. It is thought to play a role in the regulation of axonal growth and the development of synaptic plasticity. Mutations in this gene result in familial encephalopathy with neuroserpin inclusion bodies (FENIB), which is a dominantly inherited form of familial encephalopathy and epilepsy characterized by the accumulation of mutant neuroserpin polymers. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Jul 2008]
SERPINI1 Gene-Disease associations (from GenCC):
- progressive myoclonus epilepsyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- familial encephalopathy with neuroserpin inclusion bodiesInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.84 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SERPINI1 | NM_001122752.2 | c.-19+1394T>A | intron_variant | Intron 1 of 8 | ENST00000446050.7 | NP_001116224.1 | ||
| SERPINI1 | NM_005025.5 | c.-19+1082T>A | intron_variant | Intron 1 of 8 | NP_005016.1 | |||
| SERPINI1 | XM_017006618.3 | c.-19+1405T>A | intron_variant | Intron 1 of 8 | XP_016862107.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SERPINI1 | ENST00000446050.7 | c.-19+1394T>A | intron_variant | Intron 1 of 8 | 1 | NM_001122752.2 | ENSP00000397373.2 | |||
| SERPINI1 | ENST00000295777.9 | c.-19+1082T>A | intron_variant | Intron 1 of 8 | 1 | ENSP00000295777.5 | ||||
| SERPINI1 | ENST00000472747.2 | c.-19+1405T>A | intron_variant | Intron 1 of 4 | 3 | ENSP00000420561.2 | ||||
| SERPINI1 | ENST00000472941.5 | c.-19+1892T>A | intron_variant | Intron 1 of 2 | 3 | ENSP00000420133.1 |
Frequencies
GnomAD3 genomes AF: 0.559 AC: 84777AN: 151770Hom.: 26431 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
84777
AN:
151770
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.559 AC: 84872AN: 151888Hom.: 26487 Cov.: 31 AF XY: 0.550 AC XY: 40848AN XY: 74214 show subpopulations
GnomAD4 genome
AF:
AC:
84872
AN:
151888
Hom.:
Cov.:
31
AF XY:
AC XY:
40848
AN XY:
74214
show subpopulations
African (AFR)
AF:
AC:
35114
AN:
41458
American (AMR)
AF:
AC:
5478
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
1186
AN:
3460
East Asian (EAS)
AF:
AC:
1801
AN:
5166
South Asian (SAS)
AF:
AC:
1681
AN:
4806
European-Finnish (FIN)
AF:
AC:
5587
AN:
10524
Middle Eastern (MID)
AF:
AC:
99
AN:
294
European-Non Finnish (NFE)
AF:
AC:
32556
AN:
67874
Other (OTH)
AF:
AC:
975
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1640
3281
4921
6562
8202
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
686
1372
2058
2744
3430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1364
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.